《半日總結》恆指近平收 科網股受壓 油股造好
港股早市先升後回穩。投資者將資金轉投到能源等有望在經濟復甦過程中跑贏的板塊，美國道指昨晚(21日)上揚1.8%，錄得逾3個月來最大單日升幅。恆指今早高開86點後，曾升90點高見28,579點後隨即受壓，一度低見125點見28,363點。恆指半日微升0.76點報28,489點；國指跌29點或0.3%，報10,518點；恆生科技指數半日跌108點或1.4%，報7,847點。大市半日成交總額710.52億元。
科網股受壓，美團(03690.HK)、騰訊(00700.HK)、小米(01810.HK)、阿裏巴巴(09988.HK)分別跌2.5%、2.3%、1.4%、0.9%。微盟(02013.HK)、金山軟件(03888.HK)各跌逾4%。
市傳匯控(00005.HK)重組美國投行業務，四名高層離職，今日早市股價回升0.9%，造45.95元。友邦(01299.HK)及港交所(00388.HK)分別升0.2%、跌0.3%。
昨日大升的中資電訊股今早開市走個別，中移動(00941.HK)升1.1%。中電信(00728.HK)回吐2.3%。本港明起放寬社交距離措施，調高部分食肆顧客上限，煤氣(00003.HK)股價半日仍升3.7%。濠賭股銀娛(00027.HK)、金沙中國(01928.HK)則分別跌2.3%、2%。
內銀股靠穩，工行(01398.HK)、建行(00939.HK)分別升0.6%、0.2%。紐約期油升2.8%，布蘭特期油升1.9%，三桶油升3%-6.4%，其中以中石油(00857.HK)表現最好。
申洲(02313.HK)、創科(00669.HK)分別升2.2%、2.4%。藥明康德(02359.HK)參投Ambrx Biopharma於美國上市，早市股價升3.2%。藥明生物(02269.HK)升0.6%。
物管股走勢分化，世茂服務(00873.HK)一度高見24.35元。股價半日升5.7%，造24.25元。綠城服務(02869.HK)今除息，股價半日跌4.4%。
光伏、多晶硅概念股上升，福萊特玻璃(06865.HK)揚8.3%。卡姆丹克太陽能(00712.HK)、信義光能(00968.HK)、信義玻璃(00868.HK)升3.3%-4.9%。
支付寶、建行、工行等部份銀行刊發聲明稱堅決不開展、不參與任何虛擬貨幣相關業務，拖累部份比特幣概念股捱沽。美圖(01357.HK)跌1%；火幣科技(01611.HK)挫18.7%。
柏能集團(01263.HK)預告中期溢利大增至9億元，股價漲逾一成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
